nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethacrynic acid—SLC12A1—collecting duct of renal tubule—kidney cancer	0.114	0.304	CbGeAlD
Ethacrynic acid—SLC12A1—nephron—kidney cancer	0.0506	0.135	CbGeAlD
Ethacrynic acid—GSTA2—urine—kidney cancer	0.0446	0.119	CbGeAlD
Ethacrynic acid—SLC12A1—urine—kidney cancer	0.0406	0.109	CbGeAlD
Ethacrynic acid—GSTA2—Transcriptional activation by NRF2—KEAP1—kidney cancer	0.0124	0.0954	CbGpPWpGaD
Ethacrynic acid—SLC12A1—nephron tubule—kidney cancer	0.0109	0.0292	CbGeAlD
Ethacrynic acid—GSTA2—renal system—kidney cancer	0.0109	0.0292	CbGeAlD
Ethacrynic acid—SLC22A6—nephron tubule—kidney cancer	0.0106	0.0283	CbGeAlD
Ethacrynic acid—GSTA2—kidney—kidney cancer	0.0105	0.0282	CbGeAlD
Ethacrynic acid—SLC12A1—renal system—kidney cancer	0.00992	0.0266	CbGeAlD
Ethacrynic acid—GSTA2—gonad—kidney cancer	0.00978	0.0262	CbGeAlD
Ethacrynic acid—SLC12A1—kidney—kidney cancer	0.00959	0.0257	CbGeAlD
Ethacrynic acid—SLC12A1—cortex of kidney—kidney cancer	0.00934	0.025	CbGeAlD
Ethacrynic acid—SLC22A6—cortex of kidney—kidney cancer	0.00906	0.0243	CbGeAlD
Ethacrynic acid—ATP1A1—nephron tubule—kidney cancer	0.00635	0.017	CbGeAlD
Ethacrynic acid—ATP1A1—Ion transport by P-type ATPases—ATP7B—kidney cancer	0.00609	0.047	CbGpPWpGaD
Ethacrynic acid—ATP1A1—renal system—kidney cancer	0.00578	0.0155	CbGeAlD
Ethacrynic acid—ATP1A1—kidney—kidney cancer	0.00558	0.0149	CbGeAlD
Ethacrynic acid—ATP1A1—cortex of kidney—kidney cancer	0.00544	0.0146	CbGeAlD
Ethacrynic acid—ATP1A1—gonad—kidney cancer	0.00518	0.0139	CbGeAlD
Ethacrynic acid—ATP1A1—cardiac atrium—kidney cancer	0.00517	0.0138	CbGeAlD
Ethacrynic acid—GSTA2—Glutathione conjugation—GSTT1—kidney cancer	0.00473	0.0365	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—JUND—kidney cancer	0.00429	0.0331	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—ACY1—kidney cancer	0.00382	0.0295	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Ion channel transport—RYR1—kidney cancer	0.00367	0.0283	CbGpPWpGaD
Ethacrynic acid—GSTA2—Glutathione conjugation—GSTP1—kidney cancer	0.00328	0.0253	CbGpPWpGaD
Ethacrynic acid—GSTA2—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.0031	0.0239	CbGpPWpGaD
Ethacrynic acid—GSTA2—Glutathione conjugation—GSTM1—kidney cancer	0.00301	0.0232	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—JUNB—kidney cancer	0.00292	0.0225	CbGpPWpGaD
Ethacrynic acid—GSTA2—NRF2 pathway—SLC5A3—kidney cancer	0.00229	0.0177	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Preimplantation Embryo—EGR1—kidney cancer	0.00227	0.0175	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—kidney cancer	0.00214	0.0165	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Ion channel transport—ATP7B—kidney cancer	0.00211	0.0163	CbGpPWpGaD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTT1—kidney cancer	0.0021	0.0162	CbGpPWpGaD
Ethacrynic acid—Neutropenia—Vincristine—kidney cancer	0.0021	0.00422	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—ALDH1A1—kidney cancer	0.0021	0.0162	CbGpPWpGaD
Ethacrynic acid—Fatigue—Temsirolimus—kidney cancer	0.00209	0.00421	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Dactinomycin—kidney cancer	0.00209	0.0042	CcSEcCtD
Ethacrynic acid—Vision blurred—Everolimus—kidney cancer	0.00209	0.0042	CcSEcCtD
Ethacrynic acid—Pain—Temsirolimus—kidney cancer	0.00208	0.00418	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Vinblastine—kidney cancer	0.00206	0.00415	CcSEcCtD
Ethacrynic acid—Tinnitus—Sorafenib—kidney cancer	0.00206	0.00414	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Everolimus—kidney cancer	0.00205	0.00413	CcSEcCtD
Ethacrynic acid—Malaise—Vinblastine—kidney cancer	0.002	0.00403	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—KEAP1—kidney cancer	0.002	0.0154	CbGpPWpGaD
Ethacrynic acid—Vertigo—Vinblastine—kidney cancer	0.002	0.00402	CcSEcCtD
Ethacrynic acid—Malaise—Everolimus—kidney cancer	0.002	0.00402	CcSEcCtD
Ethacrynic acid—Neutropenia—Gemcitabine—kidney cancer	0.00199	0.004	CcSEcCtD
Ethacrynic acid—Decreased appetite—Pazopanib—kidney cancer	0.00199	0.004	CcSEcCtD
Ethacrynic acid—Fatigue—Pazopanib—kidney cancer	0.00197	0.00397	CcSEcCtD
Ethacrynic acid—Pain—Pazopanib—kidney cancer	0.00196	0.00394	CcSEcCtD
Ethacrynic acid—Convulsion—Vinblastine—kidney cancer	0.00192	0.00387	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Gemcitabine—kidney cancer	0.00192	0.00386	CcSEcCtD
Ethacrynic acid—Body temperature increased—Temsirolimus—kidney cancer	0.00192	0.00386	CcSEcCtD
Ethacrynic acid—Convulsion—Everolimus—kidney cancer	0.00192	0.00386	CcSEcCtD
Ethacrynic acid—GSTA2—Transcriptional activation by NRF2—PIK3CA—kidney cancer	0.00192	0.0148	CbGpPWpGaD
Ethacrynic acid—Chills—Sunitinib—kidney cancer	0.0019	0.00383	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Paclitaxel—kidney cancer	0.0019	0.00383	CcSEcCtD
Ethacrynic acid—Deafness—Capecitabine—kidney cancer	0.00189	0.00381	CcSEcCtD
Ethacrynic acid—Anxiety—Everolimus—kidney cancer	0.00188	0.00378	CcSEcCtD
Ethacrynic acid—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—kidney cancer	0.00188	0.0145	CbGpPWpGaD
Ethacrynic acid—Discomfort—Vinblastine—kidney cancer	0.00187	0.00376	CcSEcCtD
Ethacrynic acid—Discomfort—Everolimus—kidney cancer	0.00186	0.00375	CcSEcCtD
Ethacrynic acid—Anxiety—Erlotinib—kidney cancer	0.00181	0.00364	CcSEcCtD
Ethacrynic acid—Haematuria—Gemcitabine—kidney cancer	0.00181	0.00364	CcSEcCtD
Ethacrynic acid—Chills—Dactinomycin—kidney cancer	0.0018	0.00363	CcSEcCtD
Ethacrynic acid—ALB—HDL-mediated lipid transport—SCARB1—kidney cancer	0.00178	0.0138	CbGpPWpGaD
Ethacrynic acid—Dysphagia—Paclitaxel—kidney cancer	0.00178	0.00359	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Vinblastine—kidney cancer	0.00177	0.00357	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Gemcitabine—kidney cancer	0.00177	0.00356	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Everolimus—kidney cancer	0.00177	0.00356	CcSEcCtD
Ethacrynic acid—Asthenia—Temsirolimus—kidney cancer	0.00174	0.0035	CcSEcCtD
Ethacrynic acid—Anorexia—Vinblastine—kidney cancer	0.00173	0.00348	CcSEcCtD
Ethacrynic acid—Anorexia—Everolimus—kidney cancer	0.00172	0.00346	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Erlotinib—kidney cancer	0.00171	0.00343	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.00169	0.0034	CcSEcCtD
Ethacrynic acid—Neutropenia—Paclitaxel—kidney cancer	0.00167	0.00335	CcSEcCtD
Ethacrynic acid—Diarrhoea—Temsirolimus—kidney cancer	0.00166	0.00334	CcSEcCtD
Ethacrynic acid—Anorexia—Erlotinib—kidney cancer	0.00166	0.00334	CcSEcCtD
Ethacrynic acid—Asthenia—Pazopanib—kidney cancer	0.00164	0.0033	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Dactinomycin—kidney cancer	0.00162	0.00327	CcSEcCtD
Ethacrynic acid—Hyperuricaemia—Doxorubicin—kidney cancer	0.00162	0.00326	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Paclitaxel—kidney cancer	0.00161	0.00323	CcSEcCtD
Ethacrynic acid—Convulsion—Sunitinib—kidney cancer	0.0016	0.00322	CcSEcCtD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.00159	0.0123	CbGpPWpGaD
Ethacrynic acid—Malaise—Dactinomycin—kidney cancer	0.00158	0.00317	CcSEcCtD
Ethacrynic acid—Decreased appetite—Vinblastine—kidney cancer	0.00158	0.00317	CcSEcCtD
Ethacrynic acid—Decreased appetite—Everolimus—kidney cancer	0.00157	0.00316	CcSEcCtD
Ethacrynic acid—Diarrhoea—Pazopanib—kidney cancer	0.00156	0.00315	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Capecitabine—kidney cancer	0.00156	0.00314	CcSEcCtD
Ethacrynic acid—Fatigue—Everolimus—kidney cancer	0.00156	0.00313	CcSEcCtD
Ethacrynic acid—Pain—Vinblastine—kidney cancer	0.00155	0.00312	CcSEcCtD
Ethacrynic acid—Pain—Everolimus—kidney cancer	0.00154	0.00311	CcSEcCtD
Ethacrynic acid—Vomiting—Temsirolimus—kidney cancer	0.00154	0.00311	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Sorafenib—kidney cancer	0.00153	0.00309	CcSEcCtD
Ethacrynic acid—Rash—Temsirolimus—kidney cancer	0.00153	0.00308	CcSEcCtD
Ethacrynic acid—Blood uric acid increased—Doxorubicin—kidney cancer	0.00153	0.00308	CcSEcCtD
Ethacrynic acid—Dermatitis—Temsirolimus—kidney cancer	0.00153	0.00308	CcSEcCtD
Ethacrynic acid—Chills—Gemcitabine—kidney cancer	0.00153	0.00308	CcSEcCtD
Ethacrynic acid—Headache—Temsirolimus—kidney cancer	0.00152	0.00306	CcSEcCtD
Ethacrynic acid—Haematuria—Paclitaxel—kidney cancer	0.00151	0.00305	CcSEcCtD
Ethacrynic acid—Decreased appetite—Erlotinib—kidney cancer	0.00151	0.00305	CcSEcCtD
Ethacrynic acid—Fatigue—Erlotinib—kidney cancer	0.0015	0.00302	CcSEcCtD
Ethacrynic acid—Anorexia—Sorafenib—kidney cancer	0.00149	0.00301	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Vinblastine—kidney cancer	0.00149	0.00301	CcSEcCtD
Ethacrynic acid—Pain—Erlotinib—kidney cancer	0.00149	0.003	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Everolimus—kidney cancer	0.00149	0.00299	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Sunitinib—kidney cancer	0.00148	0.00297	CcSEcCtD
Ethacrynic acid—Discomfort—Dactinomycin—kidney cancer	0.00147	0.00296	CcSEcCtD
Ethacrynic acid—Dysphagia—Capecitabine—kidney cancer	0.00146	0.00294	CcSEcCtD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTP1—kidney cancer	0.00146	0.0113	CbGpPWpGaD
Ethacrynic acid—Vomiting—Pazopanib—kidney cancer	0.00145	0.00293	CcSEcCtD
Ethacrynic acid—Rash—Pazopanib—kidney cancer	0.00144	0.0029	CcSEcCtD
Ethacrynic acid—Nausea—Temsirolimus—kidney cancer	0.00144	0.0029	CcSEcCtD
Ethacrynic acid—Dermatitis—Pazopanib—kidney cancer	0.00144	0.0029	CcSEcCtD
Ethacrynic acid—Anorexia—Sunitinib—kidney cancer	0.00144	0.00289	CcSEcCtD
Ethacrynic acid—Headache—Pazopanib—kidney cancer	0.00143	0.00288	CcSEcCtD
Ethacrynic acid—Body temperature increased—Everolimus—kidney cancer	0.00143	0.00287	CcSEcCtD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.00141	0.0109	CbGpPWpGaD
Ethacrynic acid—Vertigo—Vincristine—kidney cancer	0.0014	0.00283	CcSEcCtD
Ethacrynic acid—Abdominal discomfort—Capecitabine—kidney cancer	0.0014	0.00282	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Dactinomycin—kidney cancer	0.0014	0.00281	CcSEcCtD
Ethacrynic acid—Body temperature increased—Erlotinib—kidney cancer	0.00138	0.00277	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Gemcitabine—kidney cancer	0.00138	0.00277	CcSEcCtD
Ethacrynic acid—Neutropenia—Capecitabine—kidney cancer	0.00137	0.00275	CcSEcCtD
Ethacrynic acid—Decreased appetite—Sorafenib—kidney cancer	0.00136	0.00274	CcSEcCtD
Ethacrynic acid—Anorexia—Dactinomycin—kidney cancer	0.00136	0.00274	CcSEcCtD
Ethacrynic acid—Nausea—Pazopanib—kidney cancer	0.00136	0.00273	CcSEcCtD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—HNF1A—kidney cancer	0.00136	0.0105	CbGpPWpGaD
Ethacrynic acid—Convulsion—Vincristine—kidney cancer	0.00135	0.00273	CcSEcCtD
Ethacrynic acid—Fatigue—Sorafenib—kidney cancer	0.00135	0.00272	CcSEcCtD
Ethacrynic acid—GSTA2—Phase II conjugation—GSTM1—kidney cancer	0.00134	0.0103	CbGpPWpGaD
Ethacrynic acid—Pain—Sorafenib—kidney cancer	0.00134	0.0027	CcSEcCtD
Ethacrynic acid—Malaise—Gemcitabine—kidney cancer	0.00134	0.00269	CcSEcCtD
Ethacrynic acid—Tinnitus—Paclitaxel—kidney cancer	0.00133	0.00268	CcSEcCtD
Ethacrynic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.00133	0.0103	CbGpPWpGaD
Ethacrynic acid—Hyperglycaemia—Capecitabine—kidney cancer	0.00132	0.00265	CcSEcCtD
Ethacrynic acid—Decreased appetite—Sunitinib—kidney cancer	0.00131	0.00264	CcSEcCtD
Ethacrynic acid—Asthenia—Vinblastine—kidney cancer	0.0013	0.00262	CcSEcCtD
Ethacrynic acid—Fatigue—Sunitinib—kidney cancer	0.0013	0.00262	CcSEcCtD
Ethacrynic acid—Asthenia—Everolimus—kidney cancer	0.0013	0.00261	CcSEcCtD
Ethacrynic acid—Pain—Sunitinib—kidney cancer	0.00129	0.0026	CcSEcCtD
Ethacrynic acid—Chills—Paclitaxel—kidney cancer	0.00128	0.00258	CcSEcCtD
Ethacrynic acid—ATP1A1—Preimplantation Embryo—CDH1—kidney cancer	0.00128	0.00987	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.00128	0.00985	CbGpPWpGaD
Ethacrynic acid—Jaundice—Capecitabine—kidney cancer	0.00127	0.00256	CcSEcCtD
Ethacrynic acid—Asthenia—Erlotinib—kidney cancer	0.00125	0.00252	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Vincristine—kidney cancer	0.00125	0.00251	CcSEcCtD
Ethacrynic acid—Discomfort—Gemcitabine—kidney cancer	0.00125	0.00251	CcSEcCtD
Ethacrynic acid—Haematuria—Capecitabine—kidney cancer	0.00124	0.0025	CcSEcCtD
Ethacrynic acid—Decreased appetite—Dactinomycin—kidney cancer	0.00124	0.0025	CcSEcCtD
Ethacrynic acid—Diarrhoea—Vinblastine—kidney cancer	0.00124	0.0025	CcSEcCtD
Ethacrynic acid—Body temperature increased—Sorafenib—kidney cancer	0.00124	0.00249	CcSEcCtD
Ethacrynic acid—Diarrhoea—Everolimus—kidney cancer	0.00124	0.00249	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—GSTT1—kidney cancer	0.00123	0.0095	CbGpPWpGaD
Ethacrynic acid—Fatigue—Dactinomycin—kidney cancer	0.00123	0.00248	CcSEcCtD
Ethacrynic acid—Pain—Dactinomycin—kidney cancer	0.00122	0.00246	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Capecitabine—kidney cancer	0.00122	0.00245	CcSEcCtD
Ethacrynic acid—Anorexia—Vincristine—kidney cancer	0.00122	0.00245	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—SLC5A5—kidney cancer	0.00121	0.00932	CbGpPWpGaD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	0.0012	0.00928	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Sunitinib—kidney cancer	0.00119	0.0024	CcSEcCtD
Ethacrynic acid—Diarrhoea—Erlotinib—kidney cancer	0.00119	0.0024	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Gemcitabine—kidney cancer	0.00118	0.00238	CcSEcCtD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	0.00118	0.00908	CbGpPWpGaD
Ethacrynic acid—Feeling abnormal—Dactinomycin—kidney cancer	0.00118	0.00237	CcSEcCtD
Ethacrynic acid—Vision blurred—Paclitaxel—kidney cancer	0.00117	0.00235	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—SLC2A1—kidney cancer	0.00117	0.009	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—PTGS1—kidney cancer	0.00115	0.0089	CbGpPWpGaD
Ethacrynic acid—Anorexia—Gemcitabine—kidney cancer	0.00115	0.00232	CcSEcCtD
Ethacrynic acid—Vomiting—Vinblastine—kidney cancer	0.00115	0.00232	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Paclitaxel—kidney cancer	0.00115	0.00232	CcSEcCtD
Ethacrynic acid—Vomiting—Everolimus—kidney cancer	0.00115	0.00231	CcSEcCtD
Ethacrynic acid—GSTA2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	0.00115	0.00883	CbGpPWpGaD
Ethacrynic acid—Rash—Everolimus—kidney cancer	0.00114	0.00229	CcSEcCtD
Ethacrynic acid—Dermatitis—Everolimus—kidney cancer	0.00114	0.00229	CcSEcCtD
Ethacrynic acid—Headache—Vinblastine—kidney cancer	0.00114	0.00229	CcSEcCtD
Ethacrynic acid—Headache—Everolimus—kidney cancer	0.00113	0.00228	CcSEcCtD
Ethacrynic acid—Body temperature increased—Dactinomycin—kidney cancer	0.00113	0.00227	CcSEcCtD
Ethacrynic acid—Asthenia—Sorafenib—kidney cancer	0.00112	0.00226	CcSEcCtD
Ethacrynic acid—Malaise—Paclitaxel—kidney cancer	0.00112	0.00225	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Doxorubicin—kidney cancer	0.00112	0.00225	CcSEcCtD
Ethacrynic acid—Vertigo—Paclitaxel—kidney cancer	0.00112	0.00224	CcSEcCtD
Ethacrynic acid—Decreased appetite—Vincristine—kidney cancer	0.00111	0.00223	CcSEcCtD
Ethacrynic acid—Vomiting—Erlotinib—kidney cancer	0.00111	0.00223	CcSEcCtD
Ethacrynic acid—Fatigue—Vincristine—kidney cancer	0.0011	0.00221	CcSEcCtD
Ethacrynic acid—Rash—Erlotinib—kidney cancer	0.0011	0.00221	CcSEcCtD
Ethacrynic acid—Dermatitis—Erlotinib—kidney cancer	0.0011	0.00221	CcSEcCtD
Ethacrynic acid—Headache—Erlotinib—kidney cancer	0.00109	0.0022	CcSEcCtD
Ethacrynic acid—Tinnitus—Capecitabine—kidney cancer	0.00109	0.0022	CcSEcCtD
Ethacrynic acid—Pain—Vincristine—kidney cancer	0.00109	0.0022	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.00109	0.00219	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—EGR1—kidney cancer	0.00108	0.00836	CbGpPWpGaD
Ethacrynic acid—Asthenia—Sunitinib—kidney cancer	0.00108	0.00218	CcSEcCtD
Ethacrynic acid—Nausea—Vinblastine—kidney cancer	0.00108	0.00217	CcSEcCtD
Ethacrynic acid—Convulsion—Paclitaxel—kidney cancer	0.00108	0.00216	CcSEcCtD
Ethacrynic acid—Nausea—Everolimus—kidney cancer	0.00107	0.00216	CcSEcCtD
Ethacrynic acid—Diarrhoea—Sorafenib—kidney cancer	0.00107	0.00216	CcSEcCtD
Ethacrynic acid—Anxiety—Paclitaxel—kidney cancer	0.00105	0.00212	CcSEcCtD
Ethacrynic acid—Decreased appetite—Gemcitabine—kidney cancer	0.00105	0.00212	CcSEcCtD
Ethacrynic acid—Chills—Capecitabine—kidney cancer	0.00105	0.00211	CcSEcCtD
Ethacrynic acid—Discomfort—Paclitaxel—kidney cancer	0.00104	0.0021	CcSEcCtD
Ethacrynic acid—Fatigue—Gemcitabine—kidney cancer	0.00104	0.0021	CcSEcCtD
Ethacrynic acid—Pain—Gemcitabine—kidney cancer	0.00103	0.00208	CcSEcCtD
Ethacrynic acid—Nausea—Erlotinib—kidney cancer	0.00103	0.00208	CcSEcCtD
Ethacrynic acid—Diarrhoea—Sunitinib—kidney cancer	0.00103	0.00208	CcSEcCtD
Ethacrynic acid—ALB—Lipoprotein metabolism—SCARB1—kidney cancer	0.00102	0.00791	CbGpPWpGaD
Ethacrynic acid—Asthenia—Dactinomycin—kidney cancer	0.00102	0.00206	CcSEcCtD
Ethacrynic acid—Confusional state—Paclitaxel—kidney cancer	0.00102	0.00206	CcSEcCtD
Ethacrynic acid—Body temperature increased—Vincristine—kidney cancer	0.00101	0.00203	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Doxorubicin—kidney cancer	0.00101	0.00203	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Gemcitabine—kidney cancer	0.000997	0.00201	CcSEcCtD
Ethacrynic acid—Vomiting—Sorafenib—kidney cancer	0.000997	0.00201	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Paclitaxel—kidney cancer	0.000992	0.002	CcSEcCtD
Ethacrynic acid—Rash—Sorafenib—kidney cancer	0.000988	0.00199	CcSEcCtD
Ethacrynic acid—Dermatitis—Sorafenib—kidney cancer	0.000987	0.00199	CcSEcCtD
Ethacrynic acid—Headache—Sorafenib—kidney cancer	0.000982	0.00198	CcSEcCtD
Ethacrynic acid—Diarrhoea—Dactinomycin—kidney cancer	0.000977	0.00197	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—GSTP1—kidney cancer	0.000973	0.00751	CbGpPWpGaD
Ethacrynic acid—Anorexia—Paclitaxel—kidney cancer	0.000966	0.00194	CcSEcCtD
Ethacrynic acid—Vision blurred—Capecitabine—kidney cancer	0.00096	0.00193	CcSEcCtD
Ethacrynic acid—Vomiting—Sunitinib—kidney cancer	0.000959	0.00193	CcSEcCtD
Ethacrynic acid—Body temperature increased—Gemcitabine—kidney cancer	0.000957	0.00193	CcSEcCtD
Ethacrynic acid—Rash—Sunitinib—kidney cancer	0.000951	0.00191	CcSEcCtD
Ethacrynic acid—Dermatitis—Sunitinib—kidney cancer	0.00095	0.00191	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Capecitabine—kidney cancer	0.000945	0.0019	CcSEcCtD
Ethacrynic acid—Headache—Sunitinib—kidney cancer	0.000945	0.0019	CcSEcCtD
Ethacrynic acid—Dysphagia—Doxorubicin—kidney cancer	0.000943	0.0019	CcSEcCtD
Ethacrynic acid—Nausea—Sorafenib—kidney cancer	0.000931	0.00187	CcSEcCtD
Ethacrynic acid—Malaise—Capecitabine—kidney cancer	0.000919	0.00185	CcSEcCtD
Ethacrynic acid—Vertigo—Capecitabine—kidney cancer	0.000915	0.00184	CcSEcCtD
Ethacrynic acid—Asthenia—Vincristine—kidney cancer	0.000915	0.00184	CcSEcCtD
Ethacrynic acid—Vomiting—Dactinomycin—kidney cancer	0.000908	0.00183	CcSEcCtD
Ethacrynic acid—Rash—Dactinomycin—kidney cancer	0.0009	0.00181	CcSEcCtD
Ethacrynic acid—Nausea—Sunitinib—kidney cancer	0.000896	0.0018	CcSEcCtD
Ethacrynic acid—GSTA2—NRF2 pathway—GSTM1—kidney cancer	0.000894	0.0069	CbGpPWpGaD
Ethacrynic acid—Neutropenia—Doxorubicin—kidney cancer	0.000881	0.00177	CcSEcCtD
Ethacrynic acid—Decreased appetite—Paclitaxel—kidney cancer	0.000881	0.00177	CcSEcCtD
Ethacrynic acid—Fatigue—Paclitaxel—kidney cancer	0.000874	0.00176	CcSEcCtD
Ethacrynic acid—Diarrhoea—Vincristine—kidney cancer	0.000873	0.00176	CcSEcCtD
Ethacrynic acid—Asthenia—Gemcitabine—kidney cancer	0.000868	0.00175	CcSEcCtD
Ethacrynic acid—Pain—Paclitaxel—kidney cancer	0.000866	0.00174	CcSEcCtD
Ethacrynic acid—Anxiety—Capecitabine—kidney cancer	0.000864	0.00174	CcSEcCtD
Ethacrynic acid—Discomfort—Capecitabine—kidney cancer	0.000857	0.00172	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—GSTP1—kidney cancer	0.000854	0.00659	CbGpPWpGaD
Ethacrynic acid—Hyperglycaemia—Doxorubicin—kidney cancer	0.00085	0.00171	CcSEcCtD
Ethacrynic acid—Nausea—Dactinomycin—kidney cancer	0.000848	0.00171	CcSEcCtD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000838	0.00647	CbGpPWpGaD
Ethacrynic acid—Confusional state—Capecitabine—kidney cancer	0.000838	0.00169	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Paclitaxel—kidney cancer	0.000835	0.00168	CcSEcCtD
Ethacrynic acid—Diarrhoea—Gemcitabine—kidney cancer	0.000828	0.00167	CcSEcCtD
Ethacrynic acid—Jaundice—Doxorubicin—kidney cancer	0.000819	0.00165	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Capecitabine—kidney cancer	0.000814	0.00164	CcSEcCtD
Ethacrynic acid—Vomiting—Vincristine—kidney cancer	0.000811	0.00163	CcSEcCtD
Ethacrynic acid—SLC12A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.00081	0.00625	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000808	0.00623	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000808	0.00623	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000808	0.00623	CbGpPWpGaD
Ethacrynic acid—Rash—Vincristine—kidney cancer	0.000804	0.00162	CcSEcCtD
Ethacrynic acid—Dermatitis—Vincristine—kidney cancer	0.000804	0.00162	CcSEcCtD
Ethacrynic acid—Haematuria—Doxorubicin—kidney cancer	0.000801	0.00161	CcSEcCtD
Ethacrynic acid—Body temperature increased—Paclitaxel—kidney cancer	0.000801	0.00161	CcSEcCtD
Ethacrynic acid—Headache—Vincristine—kidney cancer	0.000799	0.00161	CcSEcCtD
Ethacrynic acid—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SCARB1—kidney cancer	0.000798	0.00616	CbGpPWpGaD
Ethacrynic acid—Anorexia—Capecitabine—kidney cancer	0.000793	0.00159	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—GSTM1—kidney cancer	0.000784	0.00605	CbGpPWpGaD
Ethacrynic acid—Agranulocytosis—Doxorubicin—kidney cancer	0.000784	0.00158	CcSEcCtD
Ethacrynic acid—Vomiting—Gemcitabine—kidney cancer	0.000769	0.00155	CcSEcCtD
Ethacrynic acid—Rash—Gemcitabine—kidney cancer	0.000763	0.00154	CcSEcCtD
Ethacrynic acid—Dermatitis—Gemcitabine—kidney cancer	0.000762	0.00153	CcSEcCtD
Ethacrynic acid—Headache—Gemcitabine—kidney cancer	0.000758	0.00153	CcSEcCtD
Ethacrynic acid—Nausea—Vincristine—kidney cancer	0.000758	0.00152	CcSEcCtD
Ethacrynic acid—GSTA2—Biological oxidations—CYP1A1—kidney cancer	0.000744	0.00574	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000734	0.00566	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000734	0.00566	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000734	0.00566	CbGpPWpGaD
Ethacrynic acid—Asthenia—Paclitaxel—kidney cancer	0.000727	0.00146	CcSEcCtD
Ethacrynic acid—Decreased appetite—Capecitabine—kidney cancer	0.000723	0.00145	CcSEcCtD
Ethacrynic acid—Nausea—Gemcitabine—kidney cancer	0.000719	0.00145	CcSEcCtD
Ethacrynic acid—Fatigue—Capecitabine—kidney cancer	0.000717	0.00144	CcSEcCtD
Ethacrynic acid—Pain—Capecitabine—kidney cancer	0.000711	0.00143	CcSEcCtD
Ethacrynic acid—Tinnitus—Doxorubicin—kidney cancer	0.000703	0.00142	CcSEcCtD
Ethacrynic acid—Diarrhoea—Paclitaxel—kidney cancer	0.000693	0.0014	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Capecitabine—kidney cancer	0.000685	0.00138	CcSEcCtD
Ethacrynic acid—ALB—Lipid and lipoprotein metabolism—SCARB1—kidney cancer	0.000681	0.00525	CbGpPWpGaD
Ethacrynic acid—Chills—Doxorubicin—kidney cancer	0.000677	0.00136	CcSEcCtD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—SCARB1—kidney cancer	0.00067	0.00517	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Capecitabine—kidney cancer	0.000657	0.00132	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—ACY1—kidney cancer	0.000654	0.00505	CbGpPWpGaD
Ethacrynic acid—Vomiting—Paclitaxel—kidney cancer	0.000644	0.0013	CcSEcCtD
Ethacrynic acid—Rash—Paclitaxel—kidney cancer	0.000639	0.00129	CcSEcCtD
Ethacrynic acid—Dermatitis—Paclitaxel—kidney cancer	0.000638	0.00128	CcSEcCtD
Ethacrynic acid—Headache—Paclitaxel—kidney cancer	0.000635	0.00128	CcSEcCtD
Ethacrynic acid—Vision blurred—Doxorubicin—kidney cancer	0.000619	0.00125	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Doxorubicin—kidney cancer	0.000609	0.00123	CcSEcCtD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000604	0.00466	CbGpPWpGaD
Ethacrynic acid—Nausea—Paclitaxel—kidney cancer	0.000602	0.00121	CcSEcCtD
Ethacrynic acid—Asthenia—Capecitabine—kidney cancer	0.000597	0.0012	CcSEcCtD
Ethacrynic acid—Malaise—Doxorubicin—kidney cancer	0.000592	0.00119	CcSEcCtD
Ethacrynic acid—Vertigo—Doxorubicin—kidney cancer	0.00059	0.00119	CcSEcCtD
Ethacrynic acid—Convulsion—Doxorubicin—kidney cancer	0.000569	0.00115	CcSEcCtD
Ethacrynic acid—Diarrhoea—Capecitabine—kidney cancer	0.000569	0.00114	CcSEcCtD
Ethacrynic acid—Anxiety—Doxorubicin—kidney cancer	0.000557	0.00112	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—PDHB—kidney cancer	0.000556	0.00429	CbGpPWpGaD
Ethacrynic acid—GSTA2—Biological oxidations—POMC—kidney cancer	0.000554	0.00428	CbGpPWpGaD
Ethacrynic acid—Discomfort—Doxorubicin—kidney cancer	0.000552	0.00111	CcSEcCtD
Ethacrynic acid—ALB—Folate Metabolism—SCARB1—kidney cancer	0.000545	0.00421	CbGpPWpGaD
Ethacrynic acid—Confusional state—Doxorubicin—kidney cancer	0.00054	0.00109	CcSEcCtD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000534	0.00412	CbGpPWpGaD
Ethacrynic acid—Vomiting—Capecitabine—kidney cancer	0.000529	0.00106	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Doxorubicin—kidney cancer	0.000525	0.00106	CcSEcCtD
Ethacrynic acid—Rash—Capecitabine—kidney cancer	0.000524	0.00106	CcSEcCtD
Ethacrynic acid—Dermatitis—Capecitabine—kidney cancer	0.000524	0.00105	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—CCBL1—kidney cancer	0.000523	0.00403	CbGpPWpGaD
Ethacrynic acid—Headache—Capecitabine—kidney cancer	0.000521	0.00105	CcSEcCtD
Ethacrynic acid—Anorexia—Doxorubicin—kidney cancer	0.000511	0.00103	CcSEcCtD
Ethacrynic acid—Nausea—Capecitabine—kidney cancer	0.000494	0.000994	CcSEcCtD
Ethacrynic acid—ATP1A1—Ion channel transport—RAF1—kidney cancer	0.00048	0.0037	CbGpPWpGaD
Ethacrynic acid—Decreased appetite—Doxorubicin—kidney cancer	0.000466	0.000938	CcSEcCtD
Ethacrynic acid—Fatigue—Doxorubicin—kidney cancer	0.000462	0.00093	CcSEcCtD
Ethacrynic acid—Pain—Doxorubicin—kidney cancer	0.000458	0.000922	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—PPAT—kidney cancer	0.000453	0.0035	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GLIPR1—kidney cancer	0.000453	0.0035	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—SOD2—kidney cancer	0.000453	0.00349	CbGpPWpGaD
Ethacrynic acid—Feeling abnormal—Doxorubicin—kidney cancer	0.000442	0.000889	CcSEcCtD
Ethacrynic acid—ALB—Selenium Micronutrient Network—SCARB1—kidney cancer	0.000433	0.00334	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—PTGS1—kidney cancer	0.000429	0.00331	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000426	0.00329	CbGpPWpGaD
Ethacrynic acid—Body temperature increased—Doxorubicin—kidney cancer	0.000424	0.000853	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—FH—kidney cancer	0.000421	0.00325	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—APRT—kidney cancer	0.000421	0.00325	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000412	0.00317	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GPC3—kidney cancer	0.000396	0.00306	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000387	0.00298	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CA2—kidney cancer	0.000385	0.00297	CbGpPWpGaD
Ethacrynic acid—Asthenia—Doxorubicin—kidney cancer	0.000385	0.000774	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—ALAD—kidney cancer	0.000376	0.0029	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000374	0.00288	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—SOD2—kidney cancer	0.000368	0.00284	CbGpPWpGaD
Ethacrynic acid—Diarrhoea—Doxorubicin—kidney cancer	0.000367	0.000738	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—ST3GAL2—kidney cancer	0.000367	0.00283	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ALDH1A1—kidney cancer	0.000358	0.00276	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—SLC5A3—kidney cancer	0.000344	0.00265	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PGK1—kidney cancer	0.000344	0.00265	CbGpPWpGaD
Ethacrynic acid—Vomiting—Doxorubicin—kidney cancer	0.000341	0.000686	CcSEcCtD
Ethacrynic acid—Rash—Doxorubicin—kidney cancer	0.000338	0.00068	CcSEcCtD
Ethacrynic acid—Dermatitis—Doxorubicin—kidney cancer	0.000338	0.000679	CcSEcCtD
Ethacrynic acid—GSTA2—Metabolism—LDHB—kidney cancer	0.000337	0.0026	CbGpPWpGaD
Ethacrynic acid—Headache—Doxorubicin—kidney cancer	0.000336	0.000676	CcSEcCtD
Ethacrynic acid—ALB—Platelet degranulation—IGF2—kidney cancer	0.000333	0.00257	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000325	0.00251	CbGpPWpGaD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000318	0.00246	CbGpPWpGaD
Ethacrynic acid—Nausea—Doxorubicin—kidney cancer	0.000318	0.000641	CcSEcCtD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—kidney cancer	0.000317	0.00245	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000314	0.00242	CbGpPWpGaD
Ethacrynic acid—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000308	0.00237	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000307	0.00237	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000307	0.00237	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000307	0.00237	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000295	0.00228	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—SOD2—kidney cancer	0.000293	0.00226	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CA9—kidney cancer	0.000292	0.00225	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000278	0.00214	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—RELA—kidney cancer	0.000262	0.00202	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CRABP1—kidney cancer	0.000248	0.00192	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—L1CAM—kidney cancer	0.000243	0.00188	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—ITPR2—kidney cancer	0.00024	0.00185	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ITPR2—kidney cancer	0.000231	0.00178	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000221	0.00171	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—RELA—kidney cancer	0.000213	0.00164	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTT1—kidney cancer	0.000211	0.00162	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ACHE—kidney cancer	0.000211	0.00162	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—SCARB1—kidney cancer	0.000199	0.00154	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTGS1—kidney cancer	0.000197	0.00152	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PSMD7—kidney cancer	0.000194	0.00149	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IL2—kidney cancer	0.000192	0.00148	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ANXA2—kidney cancer	0.000184	0.00142	CbGpPWpGaD
Ethacrynic acid—SLC12A1—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000184	0.00142	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—BCHE—kidney cancer	0.000183	0.00142	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—SLC5A5—kidney cancer	0.000181	0.0014	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—SLC2A1—kidney cancer	0.000175	0.00135	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—RELA—kidney cancer	0.000169	0.0013	CbGpPWpGaD
Ethacrynic acid—ATP1A1—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000167	0.00129	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000166	0.00128	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—PTGS2—kidney cancer	0.000164	0.00127	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000162	0.00125	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.00016	0.00123	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000159	0.00123	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000159	0.00123	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000159	0.00123	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000156	0.00121	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—KCNMA1—kidney cancer	0.000153	0.00118	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IGF2—kidney cancer	0.000148	0.00114	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTP1—kidney cancer	0.000146	0.00113	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ACY1—kidney cancer	0.000142	0.0011	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—VEGFA—kidney cancer	0.00014	0.00108	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ABCB1—kidney cancer	0.000138	0.00107	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTM1—kidney cancer	0.000134	0.00103	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—GRB7—kidney cancer	0.000133	0.00103	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	0.000133	0.00103	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP1A1—kidney cancer	0.000127	0.000981	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ITPR2—kidney cancer	0.000124	0.000955	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000123	0.000952	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TP53—kidney cancer	0.000123	0.00095	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000121	0.000936	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PDHB—kidney cancer	0.000121	0.000933	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CCBL1—kidney cancer	0.000114	0.000877	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000103	0.000793	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GLIPR1—kidney cancer	9.86e-05	0.00076	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PPAT—kidney cancer	9.86e-05	0.00076	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	9.73e-05	0.000751	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	9.63e-05	0.000743	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—POMC—kidney cancer	9.48e-05	0.000731	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—APRT—kidney cancer	9.16e-05	0.000707	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—FH—kidney cancer	9.16e-05	0.000707	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IFNA1—kidney cancer	9.09e-05	0.000701	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	8.96e-05	0.000691	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GPC3—kidney cancer	8.62e-05	0.000665	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IFNA2—kidney cancer	8.46e-05	0.000653	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.41e-05	0.000649	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CA2—kidney cancer	8.38e-05	0.000647	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ALAD—kidney cancer	8.17e-05	0.00063	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	8.13e-05	0.000627	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.12e-05	0.000627	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ST3GAL2—kidney cancer	7.97e-05	0.000615	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ALDH1A1—kidney cancer	7.79e-05	0.000601	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IGF2—kidney cancer	7.62e-05	0.000588	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTGS2—kidney cancer	7.56e-05	0.000583	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC5A3—kidney cancer	7.47e-05	0.000576	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PGK1—kidney cancer	7.47e-05	0.000576	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—LDHB—kidney cancer	7.33e-05	0.000565	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	7.29e-05	0.000563	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	6.98e-05	0.000539	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTEN—kidney cancer	6.59e-05	0.000509	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.41e-05	0.000495	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CA9—kidney cancer	6.35e-05	0.00049	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.21e-05	0.000479	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	6.2e-05	0.000478	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	5.86e-05	0.000452	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	5.58e-05	0.00043	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CRABP1—kidney cancer	5.4e-05	0.000417	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ITPR2—kidney cancer	5.02e-05	0.000387	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	4.84e-05	0.000373	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CA—kidney cancer	4.65e-05	0.000359	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.63e-05	0.000357	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ACHE—kidney cancer	4.58e-05	0.000353	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTT1—kidney cancer	4.58e-05	0.000353	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SCARB1—kidney cancer	4.33e-05	0.000334	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTGS1—kidney cancer	4.29e-05	0.000331	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PSMD7—kidney cancer	4.21e-05	0.000325	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—RAF1—kidney cancer	4.19e-05	0.000323	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—BCHE—kidney cancer	3.99e-05	0.000308	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC5A5—kidney cancer	3.94e-05	0.000304	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC2A1—kidney cancer	3.8e-05	0.000294	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IL2—kidney cancer	3.76e-05	0.00029	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.69e-05	0.000285	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	3.63e-05	0.00028	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.22e-05	0.000248	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—VEGFA—kidney cancer	3.19e-05	0.000246	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTP1—kidney cancer	3.17e-05	0.000245	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—MAPK3—kidney cancer	3.02e-05	0.000233	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ABCB1—kidney cancer	3e-05	0.000232	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTM1—kidney cancer	2.92e-05	0.000225	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—MAPK1—kidney cancer	2.88e-05	0.000222	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP1A1—kidney cancer	2.76e-05	0.000213	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—KRAS—kidney cancer	2.72e-05	0.000209	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CA—kidney cancer	2.49e-05	0.000192	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TP53—kidney cancer	2.41e-05	0.000186	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.27e-05	0.000175	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—POMC—kidney cancer	2.06e-05	0.000159	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTGS2—kidney cancer	1.64e-05	0.000127	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTEN—kidney cancer	1.43e-05	0.000111	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CA—kidney cancer	1.01e-05	7.8e-05	CbGpPWpGaD
